See All Slides -

Slides

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

Presenter: Mehdi Shishehbor

October 23, 2012

Presentation TCT 2012

When Should MVD be Managed Medically?

Presenter: William Boden

October 23, 2012

Presentation TCT 2012

TCT-94. Outcomes of Patients with Severe Aortic Stenosis and Chronic Obstructive Pulmonary Disease Treated with Transcatheter Versus Surgical Aortic Valve Replacement Versus...

Presenter: Danny Dvir

October 23, 2012

Presentation TCT 2012

PCI and CABG from Bari to Syntax: Incorporating the Data Into Practice

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Presenter: Thomas McNamara

October 23, 2012

Presentation TCT 2012

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Presenter: Hendrik Treede

October 23, 2012

Presentation TCT 2012

Pathogenesis of Vulnerable Plaque 2012: What's New?

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Presentation TCT 2012

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Presenter: Andrej Schmidt

October 23, 2012

Advertisement

Slides

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Pro!

When Should MVD be Managed Medically?

TCT-94. Outcomes of Patients with Severe Aortic Stenosis and Chronic Obstructive Pulmonary Disease Treated with Transcatheter Versus Surgical Aortic Valve Replacement Versus...

PCI and CABG from Bari to Syntax: Incorporating the Data Into Practice

Blue-Toe Syndrome: Does Thrombolysis Have a Place?

Surgical Perspectives of the MitraClip and Its Role in the Treatment of Severe Degenerative and Functional MR

Pathogenesis of Vulnerable Plaque 2012: What's New?

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

HFPEF: Overview of Pathophysiology and Therapies

Debate II. Is Straight-Line Flow to the Foot Sufficient (And Is the Angiosome Concept Nonsense)? Con!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content